Akorn Sees A $10m Increase In FDA Compliance Expenditure

 
• By Akriti Seth
  
Unsuccessful -Businessman
Increased cost in FDA compliance and settlement of shareholder lawsuits reflect in Akorn’s Q2 FY19 results • Source: Shutterstock

More from Strategy

More from Business